1,2-Dichloroethane → [(2R)-3-{2-[6-(1-azetidinyl)-2-ethyl-5-fluoro-4-pyrimidinyl]hydrazino}-2-(cyclopentylmethyl)-3-oxopropyl][(phenylmethyl)oxy]formamide
Reaction equation
[N:1]1([C:5]2[C:10]([F:11])=[C:9]([NH:12][NH2:13])[N:8]=[C:7]([CH2:14][CH3:15])[N:6]=2)[CH2:4][CH2:3][CH2:2]1.[CH:16]1([CH2:21][C@H:22]([CH2:26][N:27]([CH:36]=[O:37])[O:28][CH2:29][C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[C:23](O)=[O:24])[CH2:20][CH2:19][CH2:18][CH2:17]1.C1C=NC2N(O)N=NC=2C=1.CN1CCOCC1.C(Cl)CCl>CN(C=O)C>[N:1]1([C:5]2[N:6]=[C:7]([CH2:14][CH3:15])[N:8]=[C:9]([NH:12][NH:13][C:23](=[O:24])[C@H:22]([CH2:21][CH:16]3[CH2:17][CH2:18][CH2:19][CH2:20]3)[CH2:26][N:27]([O:28][CH2:29][C:30]3[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=3)[CH:36]=[O:37])[C:10]=2[F:11])[CH2:2][CH2:3][CH2:4]1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
4-(1-Azetidinyl)-2-ethyl-5-fluoro-6-hydrazinopyrimidine (88 mg, 0.42 mmol), (2R)-3-cyclopentyl-2-({formyl[(phenylmethyl)oxy]amino}methyl)propanoic acid (140 mg, 0.46 mmol), and HOAt (56 mg, 0.42 mmol) were dissolved in 3 mL of DMF. Then, NMM (71 μL, 0.65 mmol) was added, followed by EDC (75 mg, 0.40 mmol). After stirring overnight at room temperature, the reaction mixture was purified by RP-HPLC to provide [(2R)-3-{2-[6-(1-azetidinyl)-2-ethyl-5-fluoro-4-pyrimidinyl]hydrazino}-2-(cyclopentylmethyl)-3-oxopropyl][(phenylmethyl)oxy]formamide (160 mg, 76%). LCMS: (M+H)+: 499.4.
Workup
- customthe reaction mixture was purified by RP-HPLC
Sources & evidence
- ORD record
- ord-9bf8c214bda14da4a8a36deaec63b9b6
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893056B2
Reaction notes
Loading…